Research and Markets: A Competitor Analysis Report of Toll-Like Receptor (TLR) Agonists & Antagonists

2008-09-03 23:53:01 -

www.researchandmarkets.com - Research and Markets ( www.researchandmarkets.com/research/4af4b3/competitor_analysi) has announced the addition of the "Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists" report to their offering.

The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small molecules, proteins, DNA, RNA and vaccines targeting the toll-like receptors TLR3, TLR4, TLR5, TLR7,

TLR8 and TLR9 for treatment of cancer, infectious diseases, sepsis and allergy. The analysis details molecules targeting one or more of the toll-like receptors and includes agonists, antagonists as well as vaccines and vaccine adjuvants. TLR Agonists as well as TLR Antagonists are presented sorted by receptor subtype and by therapeutic area.

A list of TLR Adjuvants used in marketed vaccines and in vaccines under development is provided. TLR-adjuvanted vaccines are compiled sorted by TLR receptor subtype and by therapeutic area as prophylactic and therapeutic vaccines. The corporate R&D portfolios (more than one project) for TLR Agonists, Antagonists, Adjuvants and TLR-Adjuvanted Vaccines is contained in this Competitor Analysis. -0- The report includes a compilation of current active projects in the research and development of TLR agonists, antagonists, adjuvants and vaccines. Competitor projects are listed in a tabular format providing information on: - Drug Codes, - Target / Mechanism of Action, - Class of Compound, - Company, - Therapeutic Area, - Product Category, - Indication, - R&D Stage and - additional comments with a hyperlink leading to the source of information. Key Topics Covered: - TLR Agonists by Receptor Subtype - TLR Agonists by Therapeutic Area - TLR Antagonists - by Receptor Subtype - TLR Antagonists - by Therapeutic Area - TLR Adjuvants by Receptor Subtype - TLR-Adjuvanted Vaccines - by Receptor Subtype - TLR-Adjuvanted Vaccines - by Therapeutic Area - Corporate TLR Agonist & Antagonist R&D Portfolios Companies Mentioned: - 3M Drug Delivery Services - Allergy Therapeutics - Ampligen - Anadys Pharmaceuticals - Cytos Biotechnology - Dynavax Technologies - GlaxoSmithKline - Idera Pharmaceuticals - Index Pharmaceuticals - Innate Pharma - Intercell - Juvaris Biotherapeutics - Meda - Merck & Co. - Merck Serono - Multicell Technologies - Novartis - Nventa Biopharmaceuticals - OM Pharma - Pfizer - Vaxart - VaxInnate - VentiRx

For more information visit www.researchandmarkets.com/research/4af4b3/competitor_analysi.

Research and Markets Ltd.
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716